These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Blood pressure-lowering medicines implemented in 12 African countries: the cross-sectional multination EIGHT study. Cavagna P; Takombe JL; Damorou JM; Kouam Kouam C; Diop IB; Ikama SM; Kramoh KE; Ali Toure I; Balde D; Dzudie A; Ferreira B; Houenassi M; Kane A; Kimbally-Kaki SG; Kingue S; Limbole E; Mfeukeu Kuate L; Mipinda JB; N'Guetta R; Nhavoto C; Sidy Ali A; Gaye B; Tajeu GS; Macquart De Terline D; Perier MC; Azizi M; Jouven X; Antignac M BMJ Open; 2021 Dec; 11(12):e049632. PubMed ID: 34857562 [TBL] [Abstract][Full Text] [Related]
3. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs. Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022 [TBL] [Abstract][Full Text] [Related]
4. Reasons for poor blood pressure control in Eastern Sub-Saharan Africa: looking into 4P's (primary care, professional, patient, and public health policy) for improving blood pressure control: a scoping review. Sorato MM; Davari M; Kebriaeezadeh A; Sarrafzadegan N; Shibru T; Fatemi B BMC Cardiovasc Disord; 2021 Mar; 21(1):123. PubMed ID: 33663387 [TBL] [Abstract][Full Text] [Related]
5. Trends in antihypertensive treatment--lessons from the National Acute Stroke Israeli (NASIS) registry. Koifman E; Tanne D; Molshatzki N; Leibowitz A; Grossman E Blood Press; 2014 Oct; 23(5):262-9. PubMed ID: 24483945 [TBL] [Abstract][Full Text] [Related]
6. Barriers to up-titrated antihypertensive strategies in 12 sub-Saharan African countries: the Multination Evaluation of hypertension in Sub-Saharan Africa Study. Cavagna P; Kramoh KE; Diop IB; Kouam Kouam C; Ikama MS; Takombe JL; Damorou JM; Ali Toure I; Balde DM; Dzudie A; Khoury S; Perier MC; Asselin A; Azizi M; Houenassi MD; Kane A; Kimbally-Kaki SG; Kingue S; Limbole E; Mfeukeu Kuate L; Mipinda JB; Ferreira B; Nhavoto C; Sidy Ali A; Empana JP; N'guetta R; Jouven X; Antignac M J Hypertens; 2022 Jul; 40(7):1411-1420. PubMed ID: 35762480 [TBL] [Abstract][Full Text] [Related]
7. Prescription pattern of antihypertensive medications and blood pressure control among hypertensive outpatients at the University of Benin Teaching Hospital in Benin City, Nigeria. Adejumo O; Okaka E; Iyawe I Malawi Med J; 2017 Jun; 29(2):113-117. PubMed ID: 28955417 [TBL] [Abstract][Full Text] [Related]
9. Office and ambulatory blood pressure control in hypertensive patients treated with different two-drug and three-drug combinations. de la Sierra A; Banegas JR; Vinyoles E; Gorostidi M; Segura J; de la Cruz JJ; Ruilope LM Clin Exp Hypertens; 2016; 38(4):409-14. PubMed ID: 27159660 [TBL] [Abstract][Full Text] [Related]
10. Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension. Chen JM; Heran BS; Perez MI; Wright JM Cochrane Database Syst Rev; 2010 Jan; (1):CD007185. PubMed ID: 20091622 [TBL] [Abstract][Full Text] [Related]
11. Combination therapies for hypertension - why we need to look beyond RAS blockers. Gorostidi M; de la Sierra A Expert Rev Clin Pharmacol; 2018 Sep; 11(9):841-853. PubMed ID: 30092149 [TBL] [Abstract][Full Text] [Related]
12. [Pharmacoepidemiological analysis of antihypertensive therapy in older age groups with senile asthenia syndrome]. Davidov EL; Yaskevich RA Ter Arkh; 2023 Jan; 94(12):1381-1386. PubMed ID: 37167182 [TBL] [Abstract][Full Text] [Related]
13. Association between cardiovascular outcomes and antihypertensive drug treatment in older women. Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological interventions for hypertension in children. Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305 [TBL] [Abstract][Full Text] [Related]
16. Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic. Volpe M; Tocci G Vasc Health Risk Manag; 2012; 8():371-80. PubMed ID: 22745561 [TBL] [Abstract][Full Text] [Related]
17. Cochrane in context: pharmacological interventions for hypertension in children. Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306 [TBL] [Abstract][Full Text] [Related]